Evidence map›Paper›PMID 26337542›Full record

ReviewJournal of nanobiotechnology2015

Silver nanoparticle protein corona and toxicity: a mini-review.

Nelson Durán, Camila P Silveira, Marcela Durán, Diego Stéfani T Martinez

Abstract readReview
In one paragraph

Review in Journal of nanobiotechnology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Characterization of Normal and Ozone StressedFood science & nutrition · 2025
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nelson DuránBiological Chemistry Laboratory, Institute of Chemistry, University of Campinas, CP 6154, Campinas, SP, CEP 13083-970, Brazil. duran@iqm.unicamp.br.
Camila P SilveiraBiological Chemistry Laboratory, Institute of Chemistry, University of Campinas, CP 6154, Campinas, SP, CEP 13083-970, Brazil. cami.silveira@gmail.com.
Marcela DuránUrogenital Carcinogenesis: Urogenital and Immunotherapy Laboratory, Institute of Biology, University of Campinas, Campinas, SP, Brazil. marceladuranduran@gmail.com.
Diego Stéfani T MartinezNanoBioss Laboratory, Institute of Chemistry, University of Campinas, Campinas, SP, Brazil. diego.martinez@lnnano.cnpem.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver nanoparticles are one of the most important materials in the nanotechnology industry. Additionally, the protein corona is emerging as a key entity at the nanobiointerface; thus, a comprehensive understanding of the interactions between proteins and silver nanoparticles is imperative. Therefore, literature reporting studies involving both single molecule protein coronas (i.e., bovine and human serum albumin, tubulin, ubiquitin and hyaluronic-binding protein) and complex protein coronas (i.e., fetal bovine serum and yeast extract proteins) were selected to demonstrate the effects of protein coronas on silver nanoparticle cytotoxicity and antimicrobial activity. There is evidence that distinct and differential protein components may yield a "protein corona signature" that is related to the size and/or surface curvature of the silver nanoparticles. Therefore, the formation of silver nanoparticle protein coronas together with the biological response to these coronas (i.e., oxidative stress, inflammation and cytotoxicity) as well as other cellular biophysicochemical mechanisms (i.e., endocytosis, biotransformation and biodistribution) will be important for nanomedicine and nanotoxicology. Researchers may benefit from the information contained herein to improve biotechnological applications of silver nanoparticles and to address related safety concerns. In summary, the main aim of this mini-review is to highlight the relationship between the formation of silver nanoparticle protein coronas and toxicity.

Indexed as

AnimalsAnti-Bacterial AgentsBacteriaBacterial InfectionsHumansModels, MolecularNanomedicineNanoparticlesProtein CoronaSilverAnti-Bacterial AgentsProtein CoronaSilver

Identifiers

PMID26337542
PMCPMC4559354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.